Skip to main content
SpringerLink
Log in
Book cover

Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors pp 119–130Cite as

Adjuvant Interferon Therapy in Primary Osteosarcoma

  • Conference paper

Abstract

Human interferons (IFN) are antiviral proteins classified into three types: α, β, and γ (Isaacs et al, 1957; Lengyel, 1982; Stewart, 1979; Strander, 1982f). Work in bacteria, including genetic analysis and purification by monoclonal antibodies, has shown that a least 15 types of human IFNs exist. The biologic implication of this fact remains to be established.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson, U., Aparisi, T., Broström, L.-Å., Cantell, K., Einhorn, S., Hall, K., Ingimarsson, S., Nilsonne, U., Strander, H., and Söderberg, G.: Interferon treatment of human osteosarcoma. Pontificiae Acad. Scient. Scripta Varia 43, 383, 1979a.

    Google Scholar 

  2. Adamson, U., Aparisi, T., Broström, L.-Å., Cantell, K., Einhorn, S., Hall, K., Ingimarsson, S., Nilsonne, U., Strander, H., and Söderberg, G.: Adjuvant interferon treatment of human osteosarcoma. In, Recent Results in Cancer Research. Eds.: G. Bonnadonna, G. Mathé and S.E. Salmon. Springer-Verlag, Berlin/Heidelberg, 68, 40, 1979b.

    Google Scholar 

  3. Aparisi, T., Strander, H., Broström, L.-Å., and Nilsonne, U.: Experience avec l’interferon dans le traitement de l’osteosarcome. Proc. of the Journées Annuelle de Chirurgie Orthopedique. Ed.: J. Duparc, 1981. (In press)

    Google Scholar 

  4. Ban, S., Yamagiwa, T., Yanagawa, T., Sakakida, K., Ito, H., Murakami, K., Matsuo, A., Imanishi, J., and Kishida, T.: Effect of human leukocyte interferon on metastatic lung tumor of osteosarcoma and primary lung cancer. In, The Clinical Potential of Interferon. Eds.: R. Kono and J. Vilćek. University of Tokyo Press, pp 223, 1982.

    Google Scholar 

  5. Berthold, W., Grazia-Masucci, M.-G., Klein, E., and Strander, H.: Interferon treatment elevates the cytotoxic potential of lymphocytes and thereby increases the frequency of functional killer cells. Human Lymphocyte Differentiation 1, 1, 1981.

    CAS  Google Scholar 

  6. Bloom, B.R.: Interferons and the immune system. Nature 285, 593, 1980.

    Article  Google Scholar 

  7. Borden, E.C., and Hawkins, J.J.: Interferons for human neoplastic and viral diseases. Comprehensive Therapy, Harvard MA, 6, 6, 1980.

    CAS  Google Scholar 

  8. Broström, L.-Å.; On the natural history of osteosarcoma. Aspects on diagnosis, prognosis and endocrinology. Acta Orthop. Scand., Suppl. No. 183, 1979.

    Google Scholar 

  9. Broström, L.Å., Aparisi, T., Ingimarsson, S., Lagergren, C., Nilsonne, U., strander, H., and Söderberg, G.: Can historical controls be used in current clinical trials in osteosarcoma? Metastases and survival in a historical and a concurrent group. Int. J. Rad. Oneal. Biol. Phys. 6, 1717, 1980a.

    Article  Google Scholar 

  10. Broström, L.-Å., Aparisi, T., Ingimarsson, S., Lagergren, C., Nilsonne, U., Strander, H., and Söderberg, G.: Can historical controls be used in current clinical trials in osteosarcoma? Analysis of prognostic factors. Int. J. Rad. Oncol. Biol. Phys. 6, 1711, 1980b.

    Article  Google Scholar 

  11. Broström, L.-Å., Ingimarsson, S., Strander, H. and Eklund, G.: Correlation between prognostic factors and blood variables in osteosarcoma. Acta Hed. Scand. 207, 429, 1980c.

    Article  Google Scholar 

  12. Broström, L.-Å., Ingimarsson, S., Strander, H., and Söderberg, G.: Adjuvant interferon treatment and late development of cerebral metastases in a patient with osteosarcoma. Acta Orthop. Scand. 51, 589, 1980d.

    Article  PubMed  Google Scholar 

  13. Broström, L.-Å., Strander, H., and Nilsonne, U.: Survival in osteosarcoma in relation to tumour size and location. Clin. Orthop. 167, 250, 1982.

    PubMed  Google Scholar 

  14. Brouty-Boyé, D.: Inhibitory effects of interferons on cell multiplication. Lymphokine Reports 1, 99, 1980.

    Google Scholar 

  15. Cantell, K., Hirvonen, S., Kauppinen, H.L. and Myllylä, G.: Production of interferon in human leukocytes from normal donors with the use of Sendai virus. Methods in Enzymology (New York) 78, 29, 1981.

    Article  CAS  Google Scholar 

  16. Cantell, K., and Strander, H.: Human leukocyte interferon for clinical use. In, Blood Leukocytes. Functions and Use in Therapy. Eds.: C.F. Högman, K. Lindahl-Kiessling, and H. Wigzell. Almqvist and Wichzell, pp 73, 1977.

    Google Scholar 

  17. Einhorn, S.: Influence of interferon on human lymphocytes. In vitro and in vivo studies on spontaneous cytotoxicity and cell surface receptors. Thesis, Sundt Offset, Stockholm, 1980.

    Google Scholar 

  18. Einhorn, S. and Strander, H.: Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J. Gen. Virol. 35, 573, 1977.

    Article  PubMed  CAS  Google Scholar 

  19. Einhorn, S. and Strander, H.: Interferon therapy for neoplastic diseases in man. In, Production of Human Interferon and Investigations of Its Clinical Use. A Symposium Workshop, May 19–20, 1977. Human Interferon. Eds.: Warren R. Stinebring and Paul J. Chapple. Plenum Publ. Corp. 159, 1978a.

    Google Scholar 

  20. Einhorn, S., Blomgren, H., and Strander, H.: Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int. J. Cancer 22, 405, 1978b.

    Article  PubMed  CAS  Google Scholar 

  21. Einhorn, S., Blomgren, H., Cantell, K., and Strander, H.: Effect of prolonged in vivo administration of leukocyte interferon on the mitogen responsiveness of human lymphocytes. Acta Med. Scand. 206, 345, 1979.

    Article  PubMed  CAS  Google Scholar 

  22. Einhorn, S., Blomgren, H. and Strander, H.: Effect of an intramuscular injection of human leukocyte interferon on blood leukocyte counts and proportions of lymphocytes forming E, EA and EAC rosettes. Int. Arch. Allergy Appl. Immun. 63, 139, 1980a.

    Article  CAS  Google Scholar 

  23. Einhorn, S., Blomgren, H., and Strander, H.: Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon. Int. J. Cancer 26, 419, 1980b.

    Article  PubMed  CAS  Google Scholar 

  24. Einhorn, S., Blomgren, H. and Strander, H.: Influence of interferon on the immune system. Proc. XIth Cong. Europ. Allergolog. Clin. Immunology, Vienna, October 6–10, 1980. In, Clinical Immunology and Allergology. Eds.: C. Steffan and H. Ludwig, Elsevier/North Holland Biomedical Press. 1981.

    Google Scholar 

  25. Einhorn, S., Ahre, A., Blomgren, H., Johansson, B., Mellstedt, H., and Strander, H.: Enhanced NK activity in patients treated by interferon-α. Relation to clinical response. In, Natural Cell-Mediated Immunity Against Tumours. In, NK Cells and Other Natural Effector Cells. Ed.: R.B. Herberman, Academic Press, 1259, 1982a.

    Google Scholar 

  26. Einhorn, S., Blomgren, H., Jarstrand, C., Strander, H., and Wasserman, J.: Influence of interferon-α therapy on different functions of the human immune system. Proc. 2nd International TNO Meeting on the Biology of the Interferon System, Rotterdam, April 18–22, 1983. (In press)

    Google Scholar 

  27. Einhorn, S., Blomgren, H., and Strander, H.: In vitro and in vivo effects of interferon on the mitogen responsiveness of human lymphocytes. Clin. Exp. Immunol. 1982b. (In press).

    Google Scholar 

  28. Glasgow, L.A., Crane, J.L., Schelupner, C.J., Kern, E.R., Youngner, J.S., and Feingold, D.S.: Activation of reticuloendothelial system macrophages and enhancement of host resistance to a transplantable osteogenic sarcoma in mice by an extract of Brucella abortus. Cancer Treat. Rep. 62, 1931, 1978a.

    PubMed  CAS  Google Scholar 

  29. Glasgow, L., Crane, J., and Kern, E.: Antitumor activity of interferon against murine osteogenic sarcoma cells in vitro. J. Natl. Cancer Inst. 60, 659, 1978b.

    CAS  Google Scholar 

  30. Glasgow, L., Crane, J., Schleupner, C.H., Kern, E., Youngner, J., and Feingold, D.: Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): Association with activation of reticuloendothelial system macrophages. Infect. Immun. 23, 19, 1979.

    PubMed  CAS  Google Scholar 

  31. Glasgow, L. and Kern, E.: Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model. J. Natl. Cancer Inst. 67, 207, 1981.

    PubMed  CAS  Google Scholar 

  32. Gresser, I.: Usefulness of the results of studies on the antitumor effects of interferon in animals to interferon therapy of patients. Recent Results of Cancer Research 75, 226, 1980.

    Article  CAS  Google Scholar 

  33. Gutterman, J.U.: Clinical investigation of the interferons in human cancer. Bulletin du Cancer 33, 271, 1981.

    Google Scholar 

  34. Ingimarsson, S.: Studies on human leukocyte interferon in clinical use. Thesis, Sundt Offset, Stockholm, 1980.

    Google Scholar 

  35. Ingimarsson, S., Cantell, K., and Strander, H.: Side effects of long-term treatment with human leukocyte interferon. J. Infect. Dis. 140, 560, 1979.

    Article  PubMed  CAS  Google Scholar 

  36. Ingimarsson, S., Cantell, K., and Strander, H.: Acute infections in patients receiving interferon. In, Interferon — Properties and Clinical Uses. Eds: A. Khan, N.O. Hill, and G.L. Dorn. Wadley Institutes, 633, 1980a.

    Google Scholar 

  37. Ingimarsson, S., Bergström, K., Broström, L.-Å., Cantell, K., and Strander, H.: Effect of long-term treatment with human leukocyte interferon on various laboratory parameters. Acta Med. Scand. 208, 155, 1980b.

    Article  PubMed  CAS  Google Scholar 

  38. Ingimarsson, S., Cantell, K., Carlström, G., and Strander, H.: Virus infections and recurrence of osteosarcoma in patients receiving human leukocyte interferon. Int. J. Cancer 26, 395, 1980c.

    Article  PubMed  CAS  Google Scholar 

  39. Ingimarsson, S., Cantell, K., Carlström, G., Dalton, B., Paucker, K. and Strander, H.: Immune reactions and long-term therapy with human leukocyte interferon. Acta Med. Scand. 209, 17, 1981.

    Article  PubMed  CAS  Google Scholar 

  40. Isaacs, A., and Lindenmann, J.: Virus interference. I. The interferons. Proc. Royal Soc. Lond. B 147, 258, 1957.

    Article  CAS  Google Scholar 

  41. Lengyel, P.: Biochemistry of interferons and their actions. Ann. Rev. Bioch. 51, 251, 1982.

    Article  CAS  Google Scholar 

  42. Merigan, T.C. and Friedman, R.M.: Interferons. New York & London, Academic Press, 1982.

    Google Scholar 

  43. Nilsonne, U., and Strander, H.: Clinical experience of interferon treatment in osteosarcoma. Proc. 12th Int. Immunobiological Symp. Yugoslav; Academy of Sciences and Arts Symp. on Interferon, Zagreb. 137, 1979.

    Google Scholar 

  44. Nilsonne, U. and Strander, H.: Traitement de l’osteosarcome par l’interferon et la chirurgie différenciée. Revue de Chirurgie Orthopedique 67, 193, 1981.

    CAS  Google Scholar 

  45. Priestman, T.J.: Interferons and cancer: The end of the beginning or the beginning of the end. Clin. Oncol. 7, 271, 1981.

    PubMed  CAS  Google Scholar 

  46. Stewart, II, W.E.: The Interferon System. Springer-Verlag, Wien & New York, 1979.

    Google Scholar 

  47. Strander, H.: Interferons: Anti-neoplastic drugs? Blut 35, 277, 1977.

    Article  PubMed  CAS  Google Scholar 

  48. Strander, H.: Mechanisms of cell growth inhibitory and antitumor action; genetics of the interferon system. Introductory remarks. Ann. New York Acd. Sci. 350, 168, 1980.

    Article  Google Scholar 

  49. Strander, H.: Interferon (IFN) therapy of tumor disease. Proc. Int. Workshop on Regulation and Modulation of Immune Activities. Hasliberg-Reuti, Feb. 24–27, 1981. In, Mikroökologie und Therapie, 11, 135, 1981a.

    Google Scholar 

  50. Strander, H.: Clinical trials conducted with interferon on tumour patients in Europe. TNO and Erasmus University Meeting on the Biology of the Interferon system, Rotterdam, Apr. 21–24, 1981. In, The Biology of the Interferon System. Eds.: E. De Maeyer, G. Galasso, and H. Schellekens. Elsevier/North-Holland Biomedical Press. 1981b.

    Google Scholar 

  51. Strander, H., Einhorn, S., Ingimarsson, S., Aparisi, T., Broström, L.-Å., Nilsonne, U., and Söderberg, G.: Treatment of human osteosarcoma with HU LEU IFN alpha. Presented at The Annual International Congress of Interferon Research, Miami, Nov. 1–4, 1982a.

    Google Scholar 

  52. Strander, H., and Einhorn, S.: Interferon in cancer — faith, hope and reality. Am. J. Clin. Oncol. 5, 297, 1982b.

    Article  PubMed  CAS  Google Scholar 

  53. Strander, H.: Interferon therapy for tumour diseases in man — prospects for the near future. Proc. 3rd Deutsche Stiftung für Krebsforschung, Bonn, March 13–16, 1981. In, Interferon — Properties, Mode of Action, Production, Clinical Application. Eds.: K. Munk and H. Kirchner, S. Karger, Heidelberg. 227, 1982c.

    Google Scholar 

  54. Strander, H.: Interferon therapy of malignant disease. In, The Clinical Potential of Interferons. Eds.: R. Kono and J. Vilćek. Universitv of Tokyo Press. 179, 1982d.

    Google Scholar 

  55. Strander, H.: Antitumor effects of interferon and its possible use as an antineoplastic agent. In, Texas Reports on Biology and Medicine — The Interferon System: A Review to 1982. 41 (in press) 1982e.

    Google Scholar 

  56. Strander, H.: The Role of Interferon in Disease. Cambridge University Press (in press) 1982f.

    Google Scholar 

  57. Strander, H.: Adjuvant treatment of osteosarcoma — some personal views. International Conference on Advances in the Adjuvant Therapy of Cancer. London, June 17–18. 1982g.

    Google Scholar 

  58. Strander, H. and Einhorn, S.: Effect of human leukocyte interferon on the growth of human osteogenic sarcoma cells in tissue culture. Int. J. Cancer 19, 468, 1977.

    Article  PubMed  CAS  Google Scholar 

  59. Strander, H., and Einhorn, S.: Interferon alpha trials in human tumor diseases. In, Chemistry and Biology of Interferons: Relationship to Therapeutics. UCLA Symposia on Molecular and Cellular Biology. XXV. Eds.: Thomas Merigan, Robert Friedman and C. Fox. Academic Press, New York, 399, 1982a.

    Google Scholar 

  60. Strander, H. and Einhorn, S.: Interferon therapy in neoplastic diseases. Phil. Trans. R. Soc. London. B, 299, 113, 1982b.

    Article  CAS  Google Scholar 

  61. Strander, H., Cantell, K., Ingimarsson, S., Jakobsson, P.A., Nilsonne, U., and Söderberg, G.: Interferon treatment of osteogenic sarcoma — a clinical trial. Conf. on Modulation of Host Immune Resistance in the Prevention or Treatment of Induced Neoplasias. December 9–11, 1974. Fogarty Int. Ctr. Proc. US Govt. Printing Office, Washington, DC 28, 377, 1977.

    Google Scholar 

  62. Strander, H., Adamson, U., Aparisi, T., Broström, L.-Å., Cantell, K., Einhorn, s., Hall, K., Ingimarsson, S., Nilsome, U., and Söderberg, G.: Adjuvant interferon treatment of human osteosarcoma. In, Recent Results in Cancer Research. Eds.: G. Bonnadonna, G. Mathé and S.E. Salmon. Springer-Verlag, Berlin-Heidelberg 68, 39, 1979.

    Google Scholar 

  63. Strander, H., Aparisi, T., Blomgren, H., Broström, L.-Å., Cantell, K., Einhorn, S., Ingimarsson, S., Nilsome, U., and Söderberg, G.: Adjuvant interferon treatment of human osteosarcoma. EORTC meeting, Paris 1980. In, Recent Results in Cancer Research, Springer-Verlag, Berlin-Heidelberg, 80, 103, 1982b.

    Google Scholar 

  64. Weissmann, C., Nagata, S., Boll, W., Fountoulakis, M., Fujisawa, A., Fujisawa, J.-I., Haynes, J., Henco, K., Mantei, N., Ragg, H., Schein, C., Schmid, J., Shaw, G., Streuli, M., Taira, H., Todokoro, K., and Weidle, U.: Structure and expression of human IFN-α genes. Phil. Trans. Royal Soc., London, B, 299, 7, 1982.

    Article  CAS  Google Scholar 

  65. WHO Scientific Group Report: Interferon therapy. Technical Report Series 676, WHO, Geneva, 1982.

    Google Scholar 

Download references

Authors
  1. H. Strander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Aparisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L.-Å. Broström
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Einhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Ingimarsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Nilsonne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Söderberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Orthopaedics, Faculty of Medicine, University of Ottawa, Canada

    Hans K. Uhthoff MD, FRCS(C) (Prof. and Head) (Prof. and Head)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Strander, H. et al. (1984). Adjuvant Interferon Therapy in Primary Osteosarcoma. In: Uhthoff, H.K. (eds) Current Concepts of Diagnosis and Treatment of Bone and Soft Tissue Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69210-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69210-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69212-3

  • Online ISBN: 978-3-642-69210-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation